Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells
Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells
复制标题
DOI:
10.1016/j.chembiol.2019.03.016
复制
发表时间:
2019-07-18
影响因子:
8.6
通讯作者:
Nomura, Daniel K.
中科院分区:
文献类型:
--
作者:
Berdan, Charles A.;Ho, Raymond;Nomura, Daniel K.
Parthenolide, a natural product from the feverfew plant and member of the large family of sesquiterpene lactones, exerts multiple biological and therapeutic activities including anti-inflammatory and anti-cancer effects. Here, we further study the parthenolide mechanism of action using activity-based protein profiling-based chemoproteomic platforms to map additional covalent targets engaged by parthenolide in human breast cancer cells. We find that parthenolide, as well as other related exocyclic methylene lactone-containing sesquiterpenes, covalently modify cysteine 427 of focal adhesion kinase 1 (FAK1), leading to impairment of FAK1-dependent signaling pathways and breast cancer cell proliferation, survival, and motility. These studies reveal a functional target exploited by members of a large family of anti-cancer natural products.